Table 3.
Multivariate predictors for death/urgent heart transplantation for all study population.
| HR | 95% CI | P | |
|---|---|---|---|
| Male sex | 1.73 | 1.13–2.67 | .014 |
| HF duration (for 12 months increase) | 1.10 | 1.06–1.14 | .002 |
| NYHA class (III–IV vs. I–II) | 1.88 | 1.24–2.83 | .002 |
| LBBB | 1.10 | 0.73–1.66 | .6 |
| LVEF (for 10 points % decrease) | 1.22 | 1.004–1.49 | .04 |
| Indexed LVEDV (for 10 ml/m2 increase) | 1.06 | 1.02–1.10 | .02 |
| Beta blockers | 0.46 | 0.31–0.70 | .0002 |
| Baseline AF | 1.49 | 0.83–2.66 | .19 |
AF=Atrial Fibrillation; HF=Heart Failure; LBBB=Left Bundle Branch Block; LVEF=Left Ventricular Ejection Fraction; LVEDV=Left Ventricular End Diastolic Volume; NYHA=New York Heart Association Class.